ID
13277
Description
Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission; ODM derived from: https://clinicaltrials.gov/show/NCT00005940
Link
https://clinicaltrials.gov/show/NCT00005940
Keywords
Versions (1)
- 1/29/16 1/29/16 -
Uploaded on
January 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Adult Acute Myeloid Leukemia in Remission NCT00005940
Eligibility Adult Acute Myeloid Leukemia in Remission NCT00005940
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
leukemic involvement of the central nervous system
Data type
boolean
Alias
- UMLS CUI [1]
- C1332884
Description
Radiation
Data type
boolean
Alias
- UMLS CUI [1]
- C0851346
Description
Informed consent
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Description
HIV
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Description
Compliance
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0851346
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C1321605
Description
Human anti-mouse antibody
Data type
boolean
Alias
- UMLS CUI [1]
- C1295018
Description
donor exclusion criteria
Data type
boolean
Alias
- UMLS CUI [1]
- C0086282
- UMLS CUI [2,1]
- C0854634
- UMLS CUI [2,2]
- C0019721
Description
Donor exclusion criteria
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0439801
- UMLS CUI [1,2]
- C1321605
- UMLS CUI [1,3]
- C0210630
- UMLS CUI [2,1]
- C0439801
- UMLS CUI [2,2]
- C1321605
- UMLS CUI [2,3]
- C3702379
Description
Donor exclusion criteria
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Similar models
Eligibility Adult Acute Myeloid Leukemia in Remission NCT00005940
- StudyEvent: Eligibility
C0009450 (UMLS CUI [2])
C2327792 (UMLS CUI [1,2])
C0086282 (UMLS CUI [1,3])
C0031437 (UMLS CUI [2,1])
C2327792 (UMLS CUI [2,2])
C0086282 (UMLS CUI [2,3])
C0019728 (UMLS CUI [3])
C0019737 (UMLS CUI [4])
C0019751 (UMLS CUI [5])
C0122040 (UMLS CUI [6])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
C0854634 (UMLS CUI [2,1])
C0019721 (UMLS CUI [2,2])
C1321605 (UMLS CUI [1,2])
C0210630 (UMLS CUI [1,3])
C0439801 (UMLS CUI [2,1])
C1321605 (UMLS CUI [2,2])
C3702379 (UMLS CUI [2,3])